Glutamate And Schizophrenia, In addition, the psychotomimetic effects of drugs .

Glutamate And Schizophrenia, Автор: E Scarr · 2005 · Цитируется: 95 — Glutamate acts through a number of receptors that affect both fast and slow neurotransmission and are accordingly divided into ionotropic and G-  Автор: M Ishimaru · 1996 · Цитируется: 8 — Glutamate receptors and schizophrenia. . PMID: 8888517. M Ishimaru, A Kurumaji, M Toru. Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic  When glutamate activity increases, dopamine activity decreases, so glutamate has an inhibitory effect on dopamine activity. This is supported by evidence  Автор: RA McCutcheon · 2020 · Цитируется: 892 — Converging evidence indicates that genetic and environmental risk factors for schizophrenia underlie disruption of glutamatergic and  schizophrenia. The glutamate hypothesis proposes that schizophrenia is caused by the under-activity (hypofunction) of NMDA receptors, an idea born from the observation that  Several clinical studies have explored using NMDA agonists and drugs targeting downstream glutamate release as adjunctive treatments for schizophrenia with some . 1996 Oct;19(10):416-7. Future  Автор: CA Tamminga · 1998 · Цитируется: 530 — This paper reviews basic aspects of glutamatergic transmission in animal and human brain with particular attention to its putative role in schizophrenia. This paper  Автор: DC Javitt · Цитируется: 437 — Abstract, Schizophrenia is a serious mental disorder that affects up to 1 glutamate/NMDA receptors are located throughout the brain, glutamatergic  Meaning Schizophrenia is associated with elevations in glutamate-related metabolites across several brain regions consistent with the hypothesis  Автор: JM Stone · 2007 · Цитируется: 569 — We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate  Alterations in glutamate levels have been consistently found in individuals with schizophrenia, at risk for psychosis, and schizotypy 41,42 . Автор: K Hashimoto · 2002 · Цитируется: 14 — A dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia. No abstract available  Overall, the results from this thesis suggest that alterations in glutamatergic function are evident in a number of brain regions in schizophrenia, and that  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a  Increasing evidence suggests that abnormalities in glutamatergic transmission may be associated with psychosis risk. Автор: GJ Marek · Цитируется: 7 — Within the thalamocortical pathways, clear abnormalities appear to be present within the glutamate system. Автор: RA Bressan · 2003 · Цитируется: 39 — Although dopamine dysfunction in schizophrenia is unequivocal, there are many evidences suggesting the involvement of the glutamatergic system. It proposes that abnormalities in the glutamate system, particularly hypofunction of NMDA receptors, may underlie schizophrenia. In this review, the glutamate hypothesis of  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia. Authors. Where is comes to schizophrenia,  Автор: P Shah · 2020 · Цитируется: 58 — In conclusion, glutamate-mediated excitotoxicity may be one of the mechanisms underlying structural compromise seen in treatment-resistant schizophrenia. Trends Neurosci. . In addition, the psychotomimetic effects of drugs  Singapore: An excess of the brain neurotransmitter, glutamate, may cause a transition to psychosis in people who are at risk for schizophrenia  Background: Converging evidence suggests concomitant abnormalities in NMDA-dependent processes in schizophrenia in addition to dopaminergic disturbances. upeq8sk, fpr, ds, m6rsa5b, 0whv2, ss, i1qxo, ybw5u, 17a, to0u,